日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reassessing prognostic markers in metastatic renal cell carcinoma in the era of immune checkpoint inhibitors: the enduring value of body composition, nutritional, and inflammatory indices

在免疫检查点抑制剂时代重新评估转移性肾细胞癌的预后标志物:身体成分、营养和炎症指标的持久价值

Tsuchiya, Norihiko; Naito, Sei; Fukuhara, Hiroki; Nishida, Hayato; Yagi, Mayu; Takai, Yuki; Yamagishi, Atsushi; Narisawa, Takafumi; Suenaga, Shinta

Exploring the crosstalk between the FGF/FGFR pathway and tumor microenvironment in clear cell renal cell carcinoma.

探索 FGF/FGFR 通路与透明细胞肾细胞癌肿瘤微环境之间的相互作用。

Narisawa Takafumi, Naito Sei, Mitsuda Yoshihide, Ohe Rintaro, Sato Hidenori, Kobayashi Chizuru, Miyano Yuki, Ito Hiromi, Futakuchi Mitsuru, Tsuchiya Norihiko

A Minimum 3-Year Follow-Up of Nivolumab-Plus-Ipilimumab in Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma: A Final Analysis of the J-ENCORE Study

一项针对日本晚期或转移性肾细胞癌患者的纳武利尤单抗联合伊匹木单抗治疗的至少3年随访研究:J-ENCORE研究的最终分析

Hamamoto, Shuzo; Nozawa, Masahiro; Shirotake, Suguru; Sazuka, Tomokazu; Numakura, Kazuyuki; Mizokami, Atsushi; Kondo, Tsunenori; Naito, Sei; Abe, Takashige; Ohba, Kojiro; Kimura, Go; Nagata, Masayoshi; Onodera, Shunta; Yamaguchi, Katsumi; Uemura, Hirotsugu

Outcomes of Nivolumab-Plus-Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J-ENCORE Study

纳武利尤单抗联合伊匹木单抗治疗转移性肾细胞癌的疗效:J-ENCORE 研究的第二次中期分析

Sazuka, Tomokazu; Tatsugami, Katsunori; Shirotake, Suguru; Hamamoto, Shuzo; Nozawa, Masahiro; Numakura, Kazuyuki; Mizokami, Atsushi; Kondo, Tsunenori; Naito, Sei; Abe, Takashige; Ohba, Kojiro; Kimura, Go; Onodera, Shunta; Yamaguchi, Katsumi; Uemura, Hirotsugu

Bladder Amyloidosis With Pulmonary Lesions: A Case of Spontaneous Remission After Transurethral Resection

膀胱淀粉样变性伴肺部病变:经尿道切除术后自发缓解一例

Ito, Suguru; Suzuki, Takuma; Sato, Ryo; Maeda, Kunihiko; Suenaga, Shinta; Kanno, Hidenori; Sato, Sadanobu; Horie, Shigemitsu; Naito, Sei; Tsuchiya, Norihiko

Comparison of IO-IO and IO-TKI Treatment Outcomes in Metastatic Renal Cell Carcinoma: Influence of Metastatic Site Count

转移性肾细胞癌中 IO-IO 和 IO-TKI 治疗结果的比较:转移部位数量的影响

Kikuchi, Hiroshi; Osawa, Takahiro; Naito, Sei; Numakura, Kazuyuki; Tokairin, Ojiro; Takai, Yuki; Sekine, Yuya; Miyata, Haruka; Matsumoto, Ryuji; Abe, Takashige; Ito, Yoichi; Habuchi, Tomonori; Tsuchiya, Norihiko; Shinohara, Nobuo

Ankrd1 Promotes Lamellipodia Formation and Cell Motility via Interaction with Talin-1 in Clear Cell Renal Cell Carcinoma.

Ankrd1 通过与 Talin-1 相互作用促进透明细胞肾细胞癌中的片状伪足形成和细胞运动

Takai Yuki, Naito Sei, Ito Hiromi, Horie Shigemitsu, Ushijima Masaki, Narisawa Takafumi, Yagi Mayu, Ichiyanagi Osamu, Tsuchiya Norihiko

A Multicenter Retrospective Study of Avelumab First-Line Maintenance and Subsequent Therapies for Locally Advanced and Metastatic Urothelial Carcinoma: Subgroup Analysis of First-Line Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, and Gemcitabine Plus Cisplatin in the Japan AVElumab MAintenance and Continuous Treatment Study (JAVEMACS)

一项针对局部晚期和转移性尿路上皮癌患者进行 Avelumab 一线维持治疗及后续治疗的多中心回顾性研究:日本 AVElumab 维持和持续治疗研究 (JAVEMACS) 中一线剂量密集型甲氨蝶呤、长春碱、多柔比星和顺铂以及吉西他滨联合顺铂方案的亚组分析

Ikeda, Masaomi; Fujimoto, Kiyohide; Miura, Noriyoshi; Taoka, Rikiya; Nishihara, Kiyoaki; Ikarashi, Daiki; Naito, Sei; Shimizu, Fumitaka; Fujihara, Atsuko; Shono, Michihiro; Nakagawa, Tohru; Kikuchi, Eiji

Real-world short-term outcomes and treatment regimen comparisons in patients with metastatic renal cell carcinoma treated with first-line immune combinations

一线免疫联合疗法治疗转移性肾细胞癌患者的真实世界短期疗效和治疗方案比较

Kikuta, Masato; Naito, Sei; Osawa, Takahiro; Numakura, Kazuyuki; Narisawa, Takafumi; Takai, Yuki; Yagi, Mayu; Sekine, Yuya; Tokairin, Ojiro; Shinohara, Nobuo; Habuchi, Tomonori; Tsuchiya, Norihiko

Characteristics of patients with metastatic renal cell carcinoma who do not respond to axitinib treatment

对阿昔替尼治疗无反应的转移性肾细胞癌患者的特征

Ohba, Kojiro; Osawa, Takahiro; Kojima, Takahiro; Hara, Tomohiko; Sugimoto, Mikio; Eto, Masatoshi; Minami, Keita; Nakai, Yasutomo; Ueda, Kosuke; Naito, Sei; Nonomura, Norio; Murai, Sachiyo; Nishiyama, Hiroyuki; Nakanishi, Hiromi; Mukae, Yuta; Mitsunari, Kensuke; Matsuo, Tomohiro; Imamura, Ryoichi; Shinohara, Nobuo